MRI as a Means to Measure Lung Function: Non-Invasive Imaging in Neonates and Children
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02163681|
Recruitment Status : Unknown
Verified October 2017 by Y. Michael Shim, MD, University of Virginia.
Recruitment status was: Recruiting
First Posted : June 16, 2014
Last Update Posted : October 19, 2017
|Condition or disease||Intervention/treatment||Phase|
|Healthy Cystic Fibrosis (CF) Asthma Bronchopulmonary Dysplasia (BPD)||Drug: Hyperpolarized Helium-3 MRI of the chest||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||77 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Actual Study Start Date :||January 2011|
|Estimated Primary Completion Date :||June 2018|
|Estimated Study Completion Date :||July 2018|
Experimental: Hyperpolarized Helium 3 MRI of the chest
Using hyperpolarized helium-3 as an inhaled contrast agent for MRI, we will assess the lung ventilation.
Drug: Hyperpolarized Helium-3 MRI of the chest
hyperpolarized helium-3 is an inhaled gaseous contrast agent for MRI and permits the acquisition of high quality imagined of lung ventilation.
- Ventilation Defects as seen on Hyperpolarized helium-3 MRI [ Time Frame: Day 1 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02163681
|Contact: Rachel Dieterich, RN||(434) email@example.com|
|Contact: Marie D Burdickfirstname.lastname@example.org|
|United States, Virginia|
|University of Virginia Health System||Recruiting|
|Charlottesville, Virginia, United States, 22908|
|Contact: Rachel Dieterich, RN 434-243-6074 email@example.com|
|Contact: Marie D Burdick 434-243-7363 firstname.lastname@example.org|
|Principal Investigator: Mike Shim, MD|